Immunovant, Inc. disclosed a stock sale filing with the SEC, while Truist Financial boosted its target price for the company.
3 reports, 2 independent
Updated Oct 9
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Immunovant, Inc. disclosed a stock sale filing with the SEC, while Truist Financial boosted its target price for the company.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.BlackRock and Two Seas Capital LP boost positions in Immunovant shares.1 source
Truist Financial boosted its target price for Immunovant, Inc. following a stock sale disclosure.1 source
Keep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- Corning saw rating changes and price target adjustments from Morgan Stanley and Truist Financial, alongside increased shareholding by the Czech National Bank.
- Retailers like Kroger and Walmart intensify competition in the grocery market, while Erste Group and Truist Financial report market movements.
Related events
- Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
- Truist Financial started coverage on Genmab shares, and TD Cowen raised rating and price target for the company, which trades on Nasdaq.
- Financial institutions including Truist Financial, Royal Bank of Canada, Bank of America, and TD Securities raised price targets on October 23, 2026.
- Truist Financial and Citigroup issued new ratings and target prices for Accel Entertainment.
- Truist Financial, Leerink partners, and Morgan Stanley have raised price targets and weighed in on Incyte stock.